Lymph node metastases have been shown to exhibit higher tumor mutational burden (TMB) and elevated programmed cell death ligand 1 (PD-L1) expression compared to corresponding primary lesions, potentially enhancing their susceptibility to ICIs (21, 22). Here, CD274 is linked to neoplasm.